🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Industry

Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand

Sreepriya Prasannan
Sreepriya Prasannan
Speed:
Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand

In response to rising demand for addiction services across Ireland, Minister Murnane O’Connor has announced €426,000 in funding for a new digital intervention tool designed to help individuals reduce their alcohol and substance use. The two-year project, funded under the Sláintecare Integration Innovation Fund, is led by HSE Health and Wellbeing and will deploy evidence-based behavioral change techniques, interactive exercises, and personalized support.

The announcement comes alongside newly published data from the Health Research Board (HRB) and the National Drug Treatment Reporting System (NDTRS) for 2025, which paints a sobering picture of problematic substance use in Ireland. According to the report, alcohol treatment cases reached a record annual high of 8,798 episodes in 2025, representing a steady upward trajectory in demand for support services.

Key Metrics from the 2025 HRB Alcohol Report

The NDTRS report highlights several critical trends in alcohol treatment across the country:

  • First-time presenters: Approximately 43% of cases in 2025 represented new individuals seeking treatment for the first time, emphasizing the need for robust early intervention strategies.
  • Dependency levels: Almost half of all treated cases were clinically classified as alcohol dependent, with an additional 30% reported as harmful drinkers.
  • Polydrug use: One of the most significant challenges identified is that nearly one in three cases required treatment for polydrug use (using alcohol in combination with other substances).

When combined with drug treatment figures, the total number of recorded treatment episodes in Ireland reached 24,220 cases in 2025-a 10% increase compared to the 22,040 episodes reported in 2024.

📈 Treatment Volume Acceleration

The 10% year-on-year increase in combined drug and alcohol treatment cases indicates a significant rising demand on public health infrastructure, emphasizing the necessity of scalable digital health solutions.

Lowering Barriers via eHealth and Prevention

The newly funded online behavioral tool aims to lower the barrier to entry for individuals who may feel hesitant to seek traditional, face-to-face clinical services. By utilizing non-judgmental, evidence-based digital pathways, the HSE plans to target marginalized groups, young people, and individuals residing in rural health regions who face geographic or social barriers to care.

Speaking on the launch, Minister Murnane O’Connor remarked: “The data published today showing alcohol treatment illustrates the harms that problem alcohol use can have on individuals, as well as their families, and communities. We need a holistic response that supports the individual and their family members to address the harms of alcohol dependency. The draft National Drugs Strategy presents an integrated response that aims to reduce the harms associated with all substances.”

Expanding Community Care: The Hub-and-Spoke Model

To support the digital app, the Department of Health is expanding its physical, integrated community alcohol services. Funding from the department has increased from €1 million in 2025 to €1.8 million in 2026 to roll out services nationwide.

These physical community centers operate on a "Hub and Spoke" model, integrated within existing acute and non-acute healthcare environments. This model ensures that individuals using the digital app can be seamlessly transitioned to in-person, multi-disciplinary community care if their clinical needs escalate.

For those seeking support or information on local resources, the HSE provides an interactive directory of over 450 drug and alcohol services nationwide. Individuals concerned about their own or a loved one’s substance use can reach the confidential Drug and Alcohol Helpline at 1800 459 459 or find resources on drugs.ie.

Digital Therapeutics and Behavioral Science in Alcohol Recovery

The €426,000 grant from the Health Research Board (HRB) to fund the development of a behavioral support app reflects the growing integration of digital therapeutics (DTx) in the Irish healthcare system. Amid record demand for addiction treatment services, public resources are under significant strain. The app utilizes Cognitive Behavioral Therapy (CBT) models and behavioral economics to help users track their alcohol intake, identify triggers, and build personalized reduction plans.

Clinicians and researchers will analyze user engagement data to evaluate the app's clinical efficacy, ensuring data privacy in compliance with GDPR. This digital tool is designed to serve as an early intervention support, helping individuals manage moderate habits before they escalate into clinical dependencies requiring specialist medical support.

Frequently Asked Questions

What is the primary goal of the €426,000 HRB-funded app?

The app is designed to provide accessible, evidence-based behavioral support to help individuals reduce their alcohol consumption, relieving pressure on public addiction treatment services.

What methodology is used in the app's design?

It utilizes Cognitive Behavioral Therapy (CBT) frameworks, habit-tracking algorithms, and personalized feedback systems designed by behavioral scientists and clinicians.

Is user data collected by the app secure?

Yes, all user data is fully anonymized, encrypted in transit and at rest, and managed in strict compliance with the Irish Health Research Regulations and GDPR.

Digital Therapeutics and Public Health Integration

The state funding for behavioral health apps reflects a growing acceptance of digital therapeutics (DTx) as a valid support tool in public health. By combining traditional face-to-face counseling with app-based behavioral monitoring, public health providers can offer more comprehensive, low-cost interventions. Continuing research into clinical outcomes will be essential to secure long-term public health integration.

Related from our data
Treatment initiation pack: Apremilast Aurobindo 10mg film-coated tablets Apremilast Aurobindo 20mg film-coated tablets Apremilast Aurobindo 30mg film-coated tablets — Apremilast, Apremilast, Apremilast · Irish Medicines Database
About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Industry

Sreepriya Prasannan is the Founder and Lead Editor of Priya Life Science. With a deep passion for the Irish pharmaceutical and MedTech sectors, she specializes in sharing actionable career insights, digital regulatory trends, and GMP compliance strategies.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment